SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001999371-24-000056
Filing Date
2024-01-03
Accepted
2024-01-03 17:02:00
Documents
12
Period of Report
2023-12-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT dmk-8k_122823.htm   iXBRL 8-K 29230
  Complete submission text file 0001999371-24-000056.txt   203435

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE dmk-20231228.xsd EX-101.SCH 3051
3 XBRL LABEL FILE dmk-20231228_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE dmk-20231228_pre.xml EX-101.PRE 22384
6 EXTRACTED XBRL INSTANCE DOCUMENT dmk-8k_122823_htm.xml XML 3296
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
DMK PHARMACEUTICALS Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 24507889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)